CD24 and neoplasm: CD24 was reported by Sinjab et al. to be at the core of an enriched cell–cell interactome in early-stage lung adenocarcinoma (LUAD), which is associated with a pro-tumor immune contexture and poor prognosis as well as promotes LUAD growth in vivo [110].